Drug
Jzp 258
Jzp 258: highest development phase Post-Market, developed by Jazz Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Jazz Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| JZP-258 NCT04794491 | Post-Market | Narcolepsy |
Latest
No recent events.
Follow Jzp 258 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.